Identifying factors that influence Alzheimer's disease progression in Hispanic individuals

Identification of endophenotypes associated with Alzheimer’s disease progression in Hispanic population

NIH-funded research University of Texas Rio Grande Valley · NIH-10448860

This study is looking at how Alzheimer's disease affects Hispanic people, who are more likely to develop it, by exploring different factors that might help us find early signs of the disease, and it's for older adults who want to contribute to better understanding and treatment of Alzheimer's in their community.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Rio Grande Valley NIH-funded
Lab location1 site (Edinburg, United States)
Project IDNIH-10448860 on NIH RePORTER

What this research studies

This research investigates the progression of Alzheimer's disease specifically in the Hispanic population, which is at a higher risk for developing this condition. By analyzing genetic, environmental, and socioeconomic factors, the study aims to identify non-invasive biomarkers that can help in the early diagnosis of Alzheimer's disease. Participants will be drawn from a large existing cohort of elderly individuals who have been thoroughly assessed for cognitive function and brain imaging. The goal is to enhance understanding of how Alzheimer's disease manifests in Hispanics and improve treatment strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are Hispanic individuals aged 55 and older who are at risk for or have been diagnosed with Alzheimer's disease.

Not a fit: Patients who are not of Hispanic descent or those under the age of 55 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease in Hispanic patients, ultimately improving their treatment and care.

How similar studies have performed: Previous research has shown promise in identifying biomarkers for Alzheimer's disease, but this specific focus on the Hispanic population is relatively novel.

Where this research is happening

Edinburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.